According to the Zhitong Finance App, Dongrui Pharmaceuticals (02348) announced that on October 23, 2026, it would spend HK$22,200 to repurchase 236,000 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.